Skip to content
HowShorted

Beam Therapeutics Inc. short interest in 2020

In 2020, Beam Therapeutics Inc.'s disclosed short interest ran from 3.92% of shares outstanding on 15 Jul 2020 to 10.46% on 31 Dec 2020, a change of +6.54 percentage points. The year's high was 10.46% on 31 Dec 2020 and its low 3.92% on 15 Jul 2020, averaging 6.52% across 12 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.78 days on 31 Jul 2020. Full history: Beam Therapeutics Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Beam Therapeutics Inc. in 2020

2020 in figures

Start of year
3.92% (15 Jul 2020)
End of year
10.46% (31 Dec 2020)
Change
+6.54 pp
High
10.46% (31 Dec 2020)
Low
3.92% (15 Jul 2020)
Average
6.52%
Highest days to cover
13.78 (31 Jul 2020)
SEC filings marked
8

Every report in 2020

Beam Therapeutics Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jul 20203.92%7.2810-K filed, results (8-K), 10-Q filed, results (8-K)
31 Jul 20204.60%13.78
14 Aug 20206.95%4.1410-Q filed, results (8-K)
31 Aug 20206.47%6.70
15 Sep 20207.03%6.98
30 Sep 20209.21%6.48
15 Oct 20205.14%3.86
30 Oct 20205.96%4.64
13 Nov 20206.38%6.7510-Q filed, results (8-K)
30 Nov 20206.47%8.90
15 Dec 20205.63%4.38
31 Dec 202010.46%4.77

See also: Beam Therapeutics Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.